Next Article in Journal
Anaerobic Degradation of Bicyclic Monoterpenes in Castellaniella defragrans
Next Article in Special Issue
Adenosine 5′-Triphosphate Metabolism in Red Blood Cells as a Potential Biomarker for Post-Exercise Hypotension and a Drug Target for Cardiovascular Protection
Previous Article in Journal
Global Metabolomics of the Placenta Reveals Distinct Metabolic Profiles between Maternal and Fetal Placental Tissues Following Delivery in Non-Labored Women
Previous Article in Special Issue
Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessEditorial
Metabolites 2018, 8(1), 11;

Metabolomics and Biomarkers for Drug Discovery

Pharmacy and Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada
Received: 18 January 2018 / Revised: 26 January 2018 / Accepted: 26 January 2018 / Published: 31 January 2018
(This article belongs to the Special Issue Metabolomics and/or Biomarkers for Drug Discovery)
Full-Text   |   PDF [156 KB, uploaded 31 January 2018]


Metabolomics and biomarkers are increasingly used in drug discovery and development, and are applied to personalized medicine. Progress in these research areas has increased our understanding of disease pathology and improved therapeutic strategies for many diseases with unmet challenges. Further advances will ultimately result in the development of better drugs and breakthrough therapies, which will benefit millions of patients suffering from chronic and life-threatening diseases worldwide. View Full-Text
Keywords: metabolomics; biomarkers; drug discovery; personalized medicine metabolomics; biomarkers; drug discovery; personalized medicine
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Yeung, P.K. Metabolomics and Biomarkers for Drug Discovery. Metabolites 2018, 8, 11.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Metabolites EISSN 2218-1989 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top